Telix Pharmaceuticals Limited Contingent Consideration Recognised As Of Acquisition Date
Telix Pharmaceuticals Limited (TLPPF) had Contingent Consideration Recognised As Of Acquisition Date of AUD 37.00 million as of 2024-04-11, per its 20-F filed 2025-02-24.
Financial Statements › Notes
ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate · last filed 2025-02-24
- 2024-04-11: Contingent Consideration Recognised As Of Acquisition Date 37.00M AUD.
AUD
| Period end | Contingent Consideration Recognised As Of Acquisition Date |
|---|---|
| 2024-04-11 | 37.00M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Contingent Consideration Recognised As Of Acquisition Date |
|---|---|
| 2024-04-11 | $24.50M 20-F · filed 2025-02-24 |